We are live on
!
Find out more
VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
1-Year Est. Return
24.67%
This Fund
S&P 500
This Quarter
Est. Return
-16.08%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
–
AUM
$1.79B
AUM Growth
-$769M
(-30%)
Cap. Flow
-$325M
Cap. Flow
% of AUM
-18.19%
Top 10 Holdings %
Top 10 Hldgs %
13.27%
Holding
993
New
75
Increased
285
Reduced
405
Closed
227
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$22.8M |
| 2 |
Globus Medical
GMED
|
+$13.6M |
| 3 |
MTLS
Materialise
MTLS
|
+$13.3M |
| 4 |
ABB
ABB Ltd
ABB
|
+$13.1M |
| 5 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$11.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zebra Technologies
ZBRA
|
+$12.4M |
| 2 |
Intuitive Surgical
ISRG
|
+$10.6M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$9.57M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$9.34M |
| 5 |
Rockwell Automation
ROK
|
+$8.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 13.46% |
| 3 | Industrials | 11.37% |
| 4 | Consumer Discretionary | 8% |
| 5 | Financials | 6.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Southwest Airlines
LUV
$23B
| $849K | 0.05% |
18,273
+8,225
| +82% | +$437K |
|
452
McKesson
MCK
$101B
| $845K | 0.05% |
7,646
+2,722
| +55% | +$339K |
|
453
Intel
INTC
$513B
| $843K | 0.05% |
17,967
-854
| -5% | -$40K |
|
454
SLB Ltd
SLB
$75B
| $842K | 0.05% |
23,337
+17,447
| +296% | +$861K |
|
455
Diamondrock Hospitality Co
DRH
$2.56B
| $835K | 0.05% |
91,929
-5,731
| -6% | -$59.1K |
|
456
NNN REIT
NNN
$8.99B
| $831K | 0.05% |
17,138
+2,693
| +19% | +$128K |
|
457
Booking.com
BKNG
$161B
| $828K | 0.05% |
12,025
-5,100
| -30% | -$374K |
|
458
DTE Energy
DTE
$29.1B
| $827K | 0.05% |
8,814
+1,168
| +15% | +$114K |
|
459
Empire State Realty Trust
ESRT
$836M
| $823K | 0.05% |
57,841
+7,284
| +14% | +$114K |
|
460
Hasbro
HAS
$13.2B
| $819K | 0.05% |
10,087
+1,863
| +23% | +$173K |
|
461
Cardinal Health
CAH
$55.4B
| $815K | 0.05% |
18,270
+1,876
| +11% | +$97.8K |
|
462
Colgate-Palmolive
CL
$74.4B
| $812K | 0.05% |
13,634
+732
| +6% | +$45.8K |
|
463
Waste Management
WM
$91B
| $810K | 0.05% |
9,104
+3,058
| +51% | +$275K |
|
464
JPMorgan Chase
JPM
$950B
| $809K | 0.05% |
+8,290
| New | +$883K |
|
465
Church & Dwight Co
CHD
$24.5B
| $807K | 0.05% |
12,264
-1,658
| -12% | -$105K |
|
466
Universal Health Services
UHS
$10.5B
| $805K | 0.05% |
6,913
-925
| -12% | -$116K |
|
467
Huntington Bancshares
HBAN
$35.5B
| $801K | 0.04% |
67,249
+37,364
| +125% | +$518K |
|
468
Capri Holdings
CPRI
$1.74B
| $794K | 0.04% |
20,928
+3,528
| +20% | +$178K |
|
469
Kimberly-Clark
KMB
$36.5B
| $793K | 0.04% |
6,956
+1,454
| +26% | +$161K |
|
470
Schneider National
SNDR
$6.25B
| $788K | 0.04% |
42,189
-5,908
| -12% | -$127K |
|
471
Advanced Micro Devices
AMD
$789B
| $780K | 0.04% |
42,279
-8,419
| -17% | -$182K |
|
|
MNR
472
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $779K | 0.04% |
62,841
+7,913
| +14% | +$115K |
|
473
Travelers Companies
TRV
$80.2B
| $778K | 0.04% |
6,495
+2,487
| +62% | +$311K |
|
|
EGRX
474
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $778K | 0.04% |
19,314
-2,710
| -12% | -$140K |
|
|
DMC
475
Del Monte Corp
DMC
$1.45B
| $776K | 0.04% |
27,435
-8,316
| -23% | -$261K |
|
Similar funds
EST
TCM
AWS
WI
JP
VCM
FCB
FCFS
Vident Investment Advisory's Q4 2018 Portfolio in Review
As of Q4 2018, Vident Investment Advisory held 993 positions worth $1.79B, down 30% from $2.55B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Vident Investment Advisory withdrew a net $325M in Q4 2018, closing 227 positions and reducing 405 holdings. Its most notable exit was Lazard, an estimated $3.82M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Vident Investment Advisory opened a new position in Globus Medical worth $11.8M.
- Vident Investment Advisory's largest Q4 2018 buy was Globus Medical: 272,897 shares worth $11.8M.
- Vident Investment Advisory added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $22.8M increase.
- Vident Investment Advisory's biggest Q4 2018 reduction was Zebra Technologies, cutting an estimated $12.4M.
- Vident Investment Advisory fully exited Lazard in Q4 2018, selling an estimated $3.82M.
- Vident Investment Advisory's ten largest holdings make up 13% of its $1.79B portfolio in Q4 2018.
- Vident Investment Advisory opened 75 new positions and closed 227 in Q4 2018.
- Vident Investment Advisory's portfolio value fell 30% quarter-over-quarter to $1.79B.
Based on Vident Investment Advisory's 13F filing for Q4 2018, filed 14 Feb 2019.